000 01269 a2200325 4500
005 20250516042809.0
264 0 _c20120416
008 201204s 0 0 eng d
022 _a1179-6901
024 7 _a10.2165/11590440-000000000-00000
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZinser-Sierra, Juan W
245 0 0 _aUse of bevacizumab in metastatic colorectal cancer: report from the Mexican opinion and analysis forum on colorectal cancer treatment with bevacizumab (September 2009).
_h[electronic resource]
260 _bDrugs in R&D
_c2011
300 _a101-11 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadverse effects
650 0 4 _aBevacizumab
650 0 4 _aBiomarkers
650 0 4 _aClinical Trials as Topic
650 0 4 _aColorectal Neoplasms
_xdiagnosis
650 0 4 _aHumans
650 0 4 _aNeoplasm Metastasis
700 1 _aRodríguez-Ramírez, Saúl
700 1 _aVillalobos-Valencia, Ricardo
700 1 _aRamírez-Márquez, Marcelino
773 0 _tDrugs in R&D
_gvol. 11
_gno. 2
_gp. 101-11
856 4 0 _uhttps://doi.org/10.2165/11590440-000000000-00000
_zAvailable from publisher's website
999 _c20933736
_d20933736